SEC Form 4 · accession 0001562180-18-001619
GENTEX CORP · GNTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Fred Bauer
Officer — Chairman of the Board & CEO · Director
Period of report
Mar 9, 2018
Accepted (ET)
Mar 13, 2018 · 2:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000355811
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 9, 2018 | M | 6,627 | $14.69 | A | 5,536,355 | D | |
| Common Stock | Mar 9, 2018 | M | 250,000 | $12.35 | A | 5,786,355 | D | |
| Common Stock | Mar 9, 2018 | M | 250,000 | $9.115 | A | 6,036,355 | D | |
| Common Stock | Mar 9, 2018 | M | 208,000 | $11.28 | A | 6,244,355 | D | |
| Common StockF1 | Mar 9, 2018 | S | 714,627 | $23.3171 | D | 5,529,728 | D | |
| Common Stock | Mar 12, 2018 | M | 149,373 | $14.69 | A | 5,679,101 | D | |
| Common Stock | Mar 12, 2018 | M | 54,000 | $15.89 | A | 5,733,101 | D | |
| Common Stock | Mar 12, 2018 | M | 28,200 | $17.97 | A | 5,761,301 | D | |
| Common StockF2 | Mar 12, 2018 | S | 231,573 | $23.3603 | D | 5,529,728 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to buy)F3 | $14.69 | Mar 9, 2018 | M | 6,627 | D | — | Sep 20, 2021 | Common Stock | 6,627 | 253,373 | D |
| Employee Stock Option (Right to buy)F4 | $12.35 | Mar 9, 2018 | M | 250,000 | D | — | Aug 11, 2018 | Common Stock | 250,000 | 0 | D |
| Employee Stock Option (Right to buy)F5 | $11.28 | Mar 9, 2018 | M | 208,000 | D | — | Aug 15, 2020 | Common Stock | 208,000 | 52,000 | D |
| Employee Stock Option (Right to buy)F4 | $9.115 | Mar 9, 2018 | M | 250,000 | D | — | Aug 16, 2019 | Common Stock | 250,000 | 0 | D |
| Employee Stock Option (Right to buy)F6 | $17.97 | Mar 12, 2018 | M | 28,200 | D | — | Aug 17, 2023 | Common Stock | 28,200 | 112,800 | D |
| Employee Stock Option (Right to buy)F7 | $15.89 | Mar 12, 2018 | M | 54,000 | D | — | Aug 19, 2022 | Common Stock | 54,000 | 81,000 | D |
| Employee Stock Option (Right to buy)F3 | $14.69 | Mar 12, 2018 | M | 149,373 | D | — | Sep 20, 2021 | Common Stock | 149,373 | 104,000 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $23.25 USD to $23.52 USD; the price reported above reflects the weighted average sale price.
- F2This transaction was executed in multiple trades at prices ranging from $23.25 USD to $23.56 USD; the price reported above reflects the weighted average sale price.
- F37-Year Grant; 20% Vesting every year for 5 years w/2 open years beginning on 20-Aug-2015.
- F4The option to purchase shares is fully vested.
- F57-Year Grant; 20% Vesting every year for 5 years w/2 open years beginning on 15-Aug-2014.
- F67-Year Grant; 20% Vesting every year for 5 years w/2 open years beginning on 18-Aug-2017.
- F77-Year Grant; 20% Vesting every year for 5 years w/2 open years beginning on 20-Aug-2015.